Evidence map›Paper›PMID 41993915›Full record

ArticleBrain, behavior, & immunity - health2026

Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence.

Emily C Hoedt, Grace L Burns, Kateleen E Hedley, Sophie Waller, Tamara Canento Sanchez, Olivia Chisolm, Helen MacCallum, Susan Richardson, Belinda Suthers, Elizabeth Pepper and 2 more

Abstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emily C HoedtCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Grace L BurnsCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Kateleen E HedleyCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Sophie WallerNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Tamara Canento SanchezNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Olivia ChisolmNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Helen MacCallumNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Susan RichardsonCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Belinda SuthersNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Elizabeth PepperNeurology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Simon KeelyCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Nicholas J TalleyCollege of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastrointestinal dysfunction, including constipation, is a common non-motor feature of Parkinson's disease (PD) and often precedes motor symptoms. The gut microbiome interacts with the host through neural, hormonal, and immune pathways, yet whether constipation represents a cause or consequence of PD remains unclear. Therefore, we aimed to interrogate the associations between microbiome and immune alterations in relation to constipation to provide novel insight into microbiome-gut-brain axis mechanisms in PD. Methods: We analysed peripheral blood mononuclear cells (PBMCs) for circulating gut-homing T cell populations and used shotgun metagenomics to profile the stool microbiome composition and functional capacity in PD patients (n = 18), healthy controls (n = 21), and individuals with constipation-predominant irritable bowel syndrome (IBS-C; n = 8). Associations between immune markers and microbial taxa were assessed, and functional pathway differences were evaluated. Results: Circulating gut-homing T cell frequencies did not differ significantly between PD and controls, but constipated PD patients showed a trend toward increased circulating gut-homing T cells. Microbiome beta-diversity analyses revealed distinct taxonomic shifts in PD and IBS-C, while functional capacity was largely conserved. Of the differential functional pathways tryptophan biosynthesis, polyamine production, and vitamin B metabolism, processes critical for neurotransmitter synthesis, epithelial integrity, and neuroimmune regulation were reduced in PD compared to IBS-C. Conclusion: Our findings highlight unique microbial and immune signatures in PD, partially overlapping with IBS-C, and underscore the importance of microbial metabolic pathways in gut-brain axis disorders. Collectively our findings suggest a contribution to dopaminergic dysfunction, neuroinflammation, and impaired gut motility. Future longitudinal studies are needed to clarify causal relationships and inform targeted interventions for PD-related gastrointestinal dysfunction.

Indexed as

Gastrointestinal microbiomeImmuneMicrobiome-gut-brain-axisParkinson's disease

Identifiers

PMID41993915
PMCPMC13081680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.